26/05/2023 04:02 PM | Click to read full article
Elon Musk's brain-chip firm says it has received approval from the US Food and Drugs Administration (FDA) to conduct its first tests on humans. The billionaire's Neuralink implant company wants to help restore people's vision and mobility by connecting brains with computers. Neuralink hopes to use its microchips to treat conditions such as paralysis and blindness, and to help certain disabled people use computers and mobile technology. The chips have been tested in monkeys.